ACETYLCHOLINE STIMULATES ALVEOLAR MACROPHAGES TO RELEASE INFLAMMATORYCELL CHEMOTACTIC ACTIVITY
Citation
E. Sato et al., ACETYLCHOLINE STIMULATES ALVEOLAR MACROPHAGES TO RELEASE INFLAMMATORYCELL CHEMOTACTIC ACTIVITY, American journal of physiology. Lung cellular and molecular physiology, 18(6), 1998, pp. 970-979
Categorie Soggetti
Physiology
SICI code
1040-0605(1998)18:6<970:ASAMTR>2.0.ZU;2-V
Abstract
Neurological transmitters including ACh, substance P(SP), and calciton
in gene-related peptide (CGRP) play an important role in regulating ai
rway tone, and increased bronchial reactivity to cholinergic stimulati
on is a well-recognized phenomenon in patients with bronchial asthma.
We postulated that ACh, SP, and CGRP might stimulate alveolar macropha
ges (AMs) to release neutrophil, monocyte, and eosinophil chemotactic
activities. To test this hypothesis, bovine AMs were isolated by bronc
hoalveolar lavage and cultured. AMs released chemotactic activities in
response to ACh in a dose-and time-dependent manner (P < 0.05). Howev
er, SP and CGRP did not stimulate bovine AMs. Checkerboard analysis re
vealed that these released activities were predominantly chemotactic.
Partial characterization and molecular-sieve column chromatography rev
ealed that low-molecular-weight lipid-soluble activity was predominant
. Lipoxygenase inhibitors significantly blocked the release of chemota
ctic activities (P < 0.05). Leukotriene Bq-and platelet-activating fac
tor-receptor antagonists blocked the chemotactic activities. Immunorea
ctive leukotriene Bq significantly increased in supernatant fluids in
response to ACh (P < 0.05), but platelet-activating factor did not. Th
e receptor responsible for the release of the chemotactic activities w
as the muscarinic Mg receptor. These data demonstrate that ACh stimula
tes AMs to release lipoxygenase-derived chemotactic activities and pla
ys a role in inflammatory cell recruitment into the airway.